Yatsen Holding Ltd
YSG NYSE Perfumes, Cosmetics & Other Toilet Preparations Financials FY2018โFY2025
What Yatsen Holding Ltd does
No business description yet.
- Legal name
- Yatsen Holding Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Apr 29, 2026
- Accession ยท CIK
- 0001193125-26-192038
0001819580
Revenue and margins
Yatsen Holding Ltd had $598M of revenue in fiscal 2025, up 26.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$19.0M in fiscal 2025, โ3.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Yatsen Holding Ltd returned $15.4M to shareholders in fiscal 2025. The diluted share count fell 8.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Yatsen Holding Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $494M | $375M | $289M | $186M | $144M |
| Current ratio | 5.2x | 6.0x | 4.8x | 3.7x | 3.6x |
| Quick ratio | 4.4x | 5.2x | 4.3x | 3.1x | 2.8x |
| Total assets | $1.1B | $850M | $705M | $544M | $549M |
| Total liabilities | $199M | $116M | $116M | $119M | $121M |
| Shareholders' equity | $891M | $684M | $582M | $419M | $430M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | 3 / 8 | 4 / 8 | 6 / 8 | 4 / 8 | 4 / 8 | 4 / 8 |
| Accruals ratio | โ | 4.1% | โ31.7% | โ6.7% | โ14.2% | โ11.6% | โ10.3% | 0.4% |
| Altman Z'' | โ | 2.91 | 5.96 | 3.95 | 4.70 | 2.34 | โ1.51 | โ0.72 |
8 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $96.0M | $439M | $758M | $905M | $550M | $482M | $472M | $598M |
| Net interest income | โ$0.0M | $0.8M | $2.1M | $7.1M | $5.1M | $12.6M | $12.0M | $5.7M |
| Provision for credit losses | โ | โ | $0.4M | โ | โ | โ | โ | โ |
| Gross profit | $60.9M | $279M | $487M | $604M | $374M | $355M | $364M | $468M |
| Research and development | $0.4M | $3.4M | $9.6M | $22.0M | $18.8M | $15.8M | $15.2M | $19.1M |
| Operating income | โ$5.0M | $20.8M | โ$389M | โ$252M | โ$138M | โ$129M | โ$115M | โ$25.8M |
| Pretax income | โ$5.5M | $21.3M | โ$388M | โ$240M | โ$122M | โ$106M | โ$99.1M | โ$12.9M |
| Income tax | $0.6M | $10.4M | $1.0M | โ$0.1M | $0.4M | โ$0.5M | โ$0.4M | โ$0.0M |
| Net income | โ$6.1M | $10.9M | โ$389M | โ$239M | โ$121M | โ$106M | โ$98.4M | โ$11.3M |
| Net income to common | โ$7.1M | โ$6.5M | โ$577M | โ$239M | โ$121M | โ | โ | โ |
| Diluted EPS | โ$0.51 | โ$0.29 | โ$13.85 | โ$1.89 | โ$1.01 | โ$0.96 | โ$0.97 | โ$0.11 |
| Diluted shares | 0.01B | 0.02B | 0.04B | 0.13B | 0.12B | 0.11B | 0.10B | 0.09B |
| Cash flow | ||||||||
| Cash from operations | โ$14.5M | โ$0.9M | โ$142M | โ$158M | $20.2M | โ$15.2M | โ$33.9M | โ$13.2M |
| Capital expenditure | $0.6M | $15.4M | $32.7M | $21.9M | $7.5M | $6.2M | $7.3M | $5.9M |
| Free cash flow | โ$15.1M | โ$16.3M | โ$175M | โ$180M | $12.7M | โ$21.3M | โ$41.2M | โ$19.0M |
| Depreciation and amortization | $0.1M | $1.9M | $10.8M | $20.3M | $16.9M | $7.6M | $5.3M | $5.1M |
| Stock-based compensation | $2.1M | $10.9M | $275M | $82.2M | $50.6M | $10.9M | $12.7M | $8.2M |
| Acquisitions | โ | $4.3M | $0.5M | $153M | $0.3M | โ | โ | โ |
| Share buybacks | โ | $6.8M | $71.2M | $2.4M | $97.2M | $30.0M | $56.4M | $15.4M |
| Dividends and buybacks | โ | $6.8M | $71.2M | $2.4M | $97.2M | $30.0M | $56.4M | $15.4M |
| Balance sheet | ||||||||
| Cash and short-term investments | โ | $98.6M | $876M | $494M | $375M | $289M | $186M | $144M |
| Current assets | โ | $226M | $1.1B | $717M | $509M | $415M | $322M | $319M |
| Current liabilities | โ | $110M | $173M | $138M | $85.3M | $86.0M | $87.7M | $87.9M |
| Inventory | โ | $72.4M | $94.3M | $110M | $61.4M | $49.6M | $52.9M | $72.7M |
| Property and equipment, net | โ | $15.7M | $43.6M | $38.6M | $11.0M | $9.1M | $10.2M | $11.0M |
| Goodwill | โ | $3.0M | $3.2M | $137M | $124M | $78.3M | $21.2M | $22.1M |
| Intangible assets | โ | $1.4M | $28.9M | $117M | $100.0M | $94.5M | $76.7M | $76.8M |
| Total assets | โ | $289M | $1.3B | $1.1B | $850M | $705M | $544M | $549M |
| Total liabilities | โ | $134M | $221M | $199M | $116M | $116M | $119M | $121M |
| Shareholders' equity | โ$8.5M | โ$8.0M | $1.0B | $891M | $684M | $582M | $419M | $430M |
| Margins | ||||||||
| Gross margin | 63.5% | 63.6% | 64.3% | 66.8% | 68.0% | 73.6% | 77.1% | 78.2% |
| Operating margin | โ5.2% | 4.7% | โ51.3% | โ27.8% | โ25.1% | โ26.7% | โ24.3% | โ4.3% |
| EBITDA margin | โ5.2% | 5.2% | โ49.8% | โ25.6% | โ22.0% | โ25.2% | โ23.2% | โ3.5% |
| Net margin | โ6.3% | 2.5% | โ51.4% | โ26.4% | โ22.0% | โ21.9% | โ20.9% | โ1.9% |
| FCF margin | โ15.7% | โ3.7% | โ23.1% | โ19.9% | 2.3% | โ4.4% | โ8.7% | โ3.2% |
| Net interest share of revenue | โ0.0% | 0.2% | 0.3% | 0.8% | 0.9% | 2.6% | 2.5% | 0.9% |
| Returns | ||||||||
| Return on capital employed | โ | 11.6% | โ35.4% | โ25.0% | โ18.0% | โ20.8% | โ25.1% | โ5.6% |
| Return on equity | โ | โ | โ74.9% | โ24.6% | โ15.4% | โ16.7% | โ19.7% | โ2.7% |
| Return on assets | โ | 3.8% | โ49.9% | โ19.8% | โ12.1% | โ13.6% | โ15.8% | โ2.1% |
| Return on tangible equity | โ | โ | โ56.8% | โ37.5% | โ26.3% | โ25.8% | โ30.7% | โ3.4% |
| Growth | ||||||||
| Revenue growth | โ | 356.9% | 72.8% | 19.4% | โ39.2% | โ12.4% | โ2.2% | 26.8% |
| Net income growth | โ | โ | โ3,670.9% | โ | โ | โ | โ | โ |
| FCF growth | โ | โ | โ | โ | โ | โ268.1% | โ | โ |
| Share count change | โ | 66.1% | 85.1% | 203.1% | โ6.1% | โ7.5% | โ7.8% | โ8.0% |
| Financial health | ||||||||
| Current ratio | โ | 2.1x | 6.3x | 5.2x | 6.0x | 4.8x | 3.7x | 3.6x |
| Quick ratio | โ | 1.4x | 5.7x | 4.4x | 5.2x | 4.3x | 3.1x | 2.8x |
| Capital allocation | ||||||||
| Capex / revenue | 0.6% | 3.5% | 4.3% | 2.4% | 1.4% | 1.3% | 1.6% | 1.0% |
| Stock comp / revenue | 2.2% | 2.5% | 36.3% | 9.1% | 9.2% | 2.3% | 2.7% | 1.4% |
| Payouts / FCF | โ | โ | โ | โ | 766.3% | โ | โ | โ |
| Quality scores | ||||||||
| Piotroski F-score | โ | โ | 3.0 | 4.0 | 6.0 | 4.0 | 4.0 | 4.0 |
| Altman Z'' | โ | 2.9 | 6.0 | 3.9 | 4.7 | 2.3 | โ1.5 | โ0.7 |
| Accruals ratio | โ | 4.1% | โ31.7% | โ6.7% | โ14.2% | โ11.6% | โ10.3% | 0.4% |
Source: SEC EDGAR XBRL filings (CIK 0001819580). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 20 ordinary shares). For information only โ not investment advice. Check the original filings before relying on any figure.
